105.50
0.00
(0.00%)
At close: January 17 at 2:40:22 PM CST
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
333,615
333,615
124,456
52,158
10,097
Cost of Revenue
50,556
50,556
17,795
4,117
1,000
Gross Profit
283,059
283,059
106,661
48,041
9,097
Operating Expense
311,009
311,009
169,937
111,800
163,443
Operating Income
-27,950
-27,950
-63,276
-63,759
-154,346
Net Non Operating Interest Income Expense
-20,094
-20,094
-8,874
-5,073
-4,502
Other Income Expense
9,174
9,174
6,630
1,633
687
Pretax Income
-38,870
-38,870
-65,520
-67,199
-158,161
Tax Provision
266
266
547
8
4
Net Income Common Stockholders
-39,136
-39,136
-66,067
-67,207
-158,165
Diluted NI Available to Com Stockholders
-39,136
-39,136
-66,067
-67,207
-158,165
Basic EPS
-0.17
-0.17
-0.30
-0.42
-1.52
Diluted EPS
-0.17
-0.17
-0.30
-0.42
-1.52
Basic Average Shares
235,232.93
235,232.93
219,331.25
158,690.08
104,205.65
Diluted Average Shares
235,232.93
235,232.93
219,331.25
158,690.08
104,205.65
Total Operating Income as Reported
-27,950
-27,950
-63,276
-63,759
-154,346
Total Expenses
361,565
361,565
187,732
115,917
164,443
Net Income from Continuing & Discontinued Operation
-39,136
-39,136
-66,067
-67,207
-158,165
Normalized Income
-39,136
-39,136
-66,067
-67,207
-158,165
Interest Expense
20,094
20,094
8,874
5,073
4,502
Net Interest Income
-20,094
-20,094
-8,874
-5,073
-4,502
EBIT
-18,776
-18,776
-56,646
-62,126
-153,659
EBITDA
-16,713
-16,713
-55,354
-60,982
-150,852
Reconciled Cost of Revenue
50,556
50,556
17,795
4,117
1,000
Reconciled Depreciation
2,063
2,063
1,292
1,144
2,807
Net Income from Continuing Operation Net Minority Interest
-39,136
-39,136
-66,067
-67,207
-158,165
Normalized EBITDA
-16,713
-16,713
-55,354
-60,982
-150,852
Tax Rate for Calcs
0
0
0
0
0
12/31/2021 - 5/4/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
B9A.F BioArctic AB (publ)
16.79
+12.46%
RPD.MU Royalty Pharma plc
28.20
0.00%
HQ1.MU Oruka Therapeutics Inc. R
7.05
+6.02%
7PO.F Poxel S.A.
0.4510
-11.39%
2HA.F Spero Therapeutics, Inc.
0.6170
+16.64%
05Y.MU Vivoryon Therapeutics NV
1.7440
-4.49%
BT3.BE Lineage Cell Therapeutics Inc
0.3800
-5.47%
PROT Proteonomix, Inc.
0.0000
0.00%
P0F.F Egetis Therapeutics AB (publ)
0.2955
-4.68%
ICY.HA Incyte Corp
52.14
+1.76%